Daiwa Securities Group
MIRM icon

Daiwa Securities Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Daiwa Securities Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-158
Closed -$12K – 1338
2025
Q4 		$12K Hold
158
– – ﹤0.01% 1177
2025
Q3 		$12K Sell
158
-20
-11% -$1.27K ﹤0.01% 1150
2025
Q2 		$9K Buy
178
+30
+20% +$1.34K ﹤0.01% 1124
2025
Q1 		$7K Sell
148
-40
-21% -$1.89K ﹤0.01% 1113
2024
Q4 		$8K Hold
188
– – ﹤0.01% 1133
2024
Q3 		$7K Buy
188
+40
+27% +$1.6K ﹤0.01% 1150
2024
Q2 		$5K Hold
148
– – ﹤0.01% 1200
2024
Q1 		$4K Hold
148
– – ﹤0.01% 1221
2023
Q4 		$4K Hold
148
– – ﹤0.01% 1227
2023
Q3 		$5K Hold
148
– – ﹤0.01% 1158
2023
Q2 		$4K Hold
148
– – ﹤0.01% 1199
2023
Q1 		$4K Hold
148
– – ﹤0.01% 1164
2022
Q4 		$3K Buy
148
+59
+66% +$1.17K ﹤0.01% 1201
2022
Q3 		$2K Hold
89
– – ﹤0.01% 1236
2022
Q2 		$2K Hold
89
– – ﹤0.01% 1245
2022
Q1 		$2K Hold
89
– – ﹤0.01% 1261
2021
Q4 		$1K Buy
+89
New +$1.39K ﹤0.01% 1345

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Daiwa Securities Group's MIRM Position: Q1 2026 in Review

Daiwa Securities Group sold out of Mirum Pharmaceuticals (MIRM) in Q1 2026, closing a stake of 158 shares — an estimated $12K sold.

Daiwa Securities Group first reported a position in MIRM in Q4 2021 and held it in 17 quarters. The position peaked at $12K in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Daiwa Securities Group reported no remaining Mirum Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 158 Mirum Pharmaceuticals shares in Q1 2026, an estimated $12K.
  • Daiwa Securities Group first reported a position in Mirum Pharmaceuticals in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Mirum Pharmaceuticals position peaked at $12K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.